Human MIP-3 beta PharmaGenie ELISA Kit (SBRS0888)

MIP-3 beta, also known as CCL19, is a CC-family chemokine that orchestrates lymphocyte homing toward lymphoid tissues by engaging the CCR7 receptor. Researchers use this quantitative immunoassay to measure CCL19 release in inflammatory disease models, tumor microenvironment studies, and chemokine signaling investigations. Standard protocol uses a 100 µL sample volume per well. Provided as a complete microplate format with pre-coated capture antibody, biotinylated detection reagent, and streptavidin-HRP conjugate. Store all components refrigerated at 2 to 8 °C and protect the substrate from light. Assay Genie supplies this ELISA for research use only, enabling reproducible quantification of human CCL19 across immunology and oncology workflows.